2m 2m 2m 2m 2m 2m 2m
Inhibrx Bio (INBX)
NASDAQ
$92.42+$0.25 (+0.28%)
Price as of Jul 13, 2026 4:27 PM EDT- $1.4BMarket Cap
- 301.42%1-Year Change
- BiotechnologyIndustry
Inhibrx Bio (INBX)
$92.42+$0.25 (+0.28%)
INBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $92.17 | ||
Change | -$0.84 (-0.91%) | ||
Open | $90.85 | ||
High | $94.38 | ||
Low | $88.77 | ||
Previous Close | $93.01 | ||
Volume | 233,384 | ||
30-Day Average Volume | 377,395 | ||
1-Week Change | -5.12% | ||
1-Month Change | -0.04% | ||
1-Year Change | 301.42% | ||
3-Year Change | 267.34% | ||
5-Year Change | 250.70% | ||
Fundamentals | |||
Shares Outstanding | 14.7M | ||
Total Assets | $184.0M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$33.4M | ||
Free Cash Flow | -$38.0M | ||
EBIT | -$29.9M | ||
EBITDA | -$29.4M | ||
Net Working Capital | $144.8M | ||
EPS | -$2.15 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -65 | ||
P/E | -43 | ||
PEG | 25 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue